As biologics developers face mounting pressure to increase output while controlling costs, perfusion-based manufacturing attracts renewed attention. Advances in media, automation, and AI-driven process control are helping overcome barriers to adoption and accelerating commercial deployment. The post Perfusion Technologies Gain Momentum in Biomanufacturing appeared first on GEN – Genetic Engineering and Biotechnology News.
You may also like
This common pesticide may be quietly wiping out future...
Boehringer Ingelheim’s Jascayd approved by MHRA for...
Ipsen to acquire Memo Therapeutics in deal worth more...
Macrophage Membrane-Derived Nanoparticles Shows...
Epigenomic Analysis Uncovers New AML Subgroups and...
GSK, Hansoh ADC extends survival in lung cancer study
About the author
David Miller
a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.